Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
CODEXIS, INC.
Georgia Erbez, a director at Codexis, Inc., reported changes in her beneficial ownership of company securities effective October 12, 2026. This filing is a standard Form 4 disclosure regarding insider stock transactions.…more
CODEXIS, INC.
Alison Moore, an insider at Codexis, Inc., reported a change in beneficial ownership of securities effective October 12, 2026. This filing serves as a standard disclosure regarding the insider's equity holdings.…more
CODEXIS, INC.
Georgia Erbez, an executive at Codexis, Inc., has filed Form 144 regarding the proposed sale of company securities. This filing serves as a notification of the insider's plan to dispose of shares.…more
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Codexis Signs Technology Agreement for siRNA Manufacturing Platform
Codexis has entered into an agreement with an siRNA drug innovator to explore its ECO Synthesis manufacturing platform for stereo-defined fragment synthesis. This collaboration serves as a validation step for the technology's potential, though no specific financial terms were disclosed.…more
●●●●●●●● ●●●●● ●●●●●●
Codexis will participate in the Cantor Global Healthcare Conference scheduled for September 9-11, 2026. Management is set to engage in a fireside chat on September 10 to discuss the company's business and technology.…more
●●●●●●●● ●●●●● ●●●●●●
코덱시스는 2분기 매출 1,490만 달러를 기록하며 연간 재무 가이던스를 유지한다고 발표했습니다. 또한 약 2,500만 달러 규모의 자본 조달을 성공적으로 완료하여 운영 자금을 확보했습니다.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.